Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
8.01
+0.27 (3.49%)
Apr 8, 2026, 3:55 PM EDT - Market open

Solid Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
61.1280.2474.02155.38119.14
Short-Term Investments
127.9568.6949.6358.3488.64
Cash & Short-Term Investments
189.07148.92123.64213.72207.78
Cash Growth
26.96%20.45%-42.15%2.86%34.27%
Other Receivables
----0.11
Total Trade Receivables
----0.11
Other Current Assets
16.388.386.095.9214.72
Total Current Assets
205.46157.3129.73219.64222.61
Net Property, Plant & Equipment
26.0929.0433.1638.617.6
Other Long-Term Assets
0.992.322.042.012.16
Total Assets
232.54188.66164.94260.25232.38
Accounts Payable
3.224.242.033.244.46
Accrued Expenses
18.9519.8510.1616.699.53
Current Portion of Leases
2.13.022.322.571.5
Unearned Revenue
----8.08
Other Current Liabilities
9.23.15-0.010.04
Total Current Liabilities
33.4730.2614.5222.5123.6
Long-Term Leases
19.0621.1623.9425.980.57
Other Long-Term Liabilities
---0.1-
Total Long-Term Liabilities
19.0621.1623.9426.080.57
Total Liabilities
52.5351.4238.4648.5924.17
Common Stock
0.080.040.020.020.01
Additional Paid-in Capital
1,138920.61785.2774.45685.01
Accumulated Other Comprehensive Income
0.050.050.02-0.07-0.05
Retained Earnings
-957.78-783.45-658.75-562.74-476.76
Shareholders' Equity
180.01137.25126.48211.67208.21
Total Liabilities & Equity
232.54188.66164.94260.25232.38
Total Debt
21.1624.1826.2728.552.06
Net Cash (Debt)
167.91124.7497.38185.18205.72
Net Cash Growth
34.61%28.11%-47.41%-9.98%37.52%
Net Cash Per Share
1.923.064.9021.7528.90
Book Value
180.01137.25126.48211.67208.21
Book Value Per Share
2.063.366.3624.8729.25
Tangible Book Value
180.01137.25126.48211.67208.21
Tangible Book Value Per Share
2.063.366.3624.8729.25
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q